Page last updated: 2024-08-25

clarithromycin and carbamates

clarithromycin has been researched along with carbamates in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bui, MH; Chu, DT; Elliott, RL; Ewing, PJ; Flamm, RK; Griesgraber, G; Henry, RF; Kim, K; Nilius, AM; Or, YS; Pireh, D; Plattner, JJ; Raney, PM1
Brophy, DF; Chittick, GE; Gillotin, C; Israel, DS; Lou, Y; Pastor, A; Polk, RE; Sadler, BM; Symonds, WT1
Kivistö, KT; Neuvonen, PJ; Niemi, M1
Khamaisi, M; Leitersdorf, E1
Jin, ZP; Lei, PS; Li, Y; Liu, J; Liu, L; Wang, GQ; Xu, P1

Trials

2 trial(s) available for clarithromycin and carbamates

ArticleYear
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:4

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-HIV Agents; Area Under Curve; Biotransformation; Breath Tests; Carbamates; Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Erythromycin; Furans; Half-Life; Humans; Liver Function Tests; Male; Mixed Function Oxygenases; Sulfonamides

2000
The cytochrome P4503A4 inhibitor clarithromycin increases the plasma concentrations and effects of repaglinide.
    Clinical pharmacology and therapeutics, 2001, Volume: 70, Issue:1

    Topics: Adult; Analysis of Variance; Anti-Bacterial Agents; Blood Glucose; Carbamates; Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypoglycemic Agents; Insulin; Male; Mixed Function Oxygenases; Piperidines; Reference Values; Time Factors

2001

Other Studies

3 other study(ies) available for clarithromycin and carbamates

ArticleYear
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
    Journal of medicinal chemistry, 1998, May-07, Volume: 41, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Carbamates; Clarithromycin; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Mice; Molecular Conformation; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Virginiamycin

1998
Severe hypoglycemia from clarithromycin-repaglinide drug interaction.
    Pharmacotherapy, 2008, Volume: 28, Issue:5

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Blood Glucose; Carbamates; Clarithromycin; Diabetes Mellitus, Type 2; Drug Interactions; Helicobacter Infections; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Piperidines

2008
Synthesis and antibacterial activity of 4''-O-heteroarylcarbamoyl derivatives of macrolide.
    Bioorganic & medicinal chemistry letters, 2008, Oct-15, Volume: 18, Issue:20

    Topics: Anti-Bacterial Agents; Carbamates; Chemistry, Pharmaceutical; Clarithromycin; Crystallography, X-Ray; Drug Design; Enterococcus faecalis; Erythromycin; Macrolides; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Chemical; Protein Synthesis Inhibitors

2008